Renaissance Acquisition Holdings

Mylan to acquire Renaissance’s Specialty and Generics Business for $1B

Monday, May 16, 2016

Mylan has announced an agreement to acquire the non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings for $950 million in cash at closing, plus additional contingent payments of up to $50 million, subject to customary adjustments. The transaction is expected to be immediately accretive to Mylan’s adjusted diluted earnings per share upon closing.

[Read More]